Grifols SA

1GRF

Company Profile

  • Business description

    Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

  • Contact

    Avinguda de la Generalitat, 152-158
    Parc de Negocis Can Sant Joan
    Sant Cugat del Valles
    Barcelona08174
    ESP

    T: +34 935710500

    E: [email protected]

    https://www.grifols.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    23,800

Stocks News & Analysis

stocks

Undervalued ASX share with plan to mitigate tariff risk

Shares have dropped 20% in the previous year due to concerns about tariffs.
stocks

Earnings up but shares overvalued for ASX gold miner

Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks

Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%

We see faster cloud growth and improved longer-term profitability for Alphabet.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,295.8026.20-0.28%
CAC 408,226.6512.53-0.15%
DAX 4024,246.7262.06-0.26%
Dow JONES (US)47,544.59337.470.71%
FTSE 1009,658.865.040.05%
HKSE26,346.1487.56-0.33%
NASDAQ23,637.46432.591.86%
Nikkei 22550,219.18293.14-0.58%
NZX 50 Index13,402.6611.070.08%
S&P 5006,875.1683.471.23%
S&P/ASX 2009,012.5016.30-0.18%
SSE Composite Index3,988.228.72-0.22%

Market Movers